These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6791048)

  • 1. Pharmacology of valproic acid in children with severe epilepsy: clearance and hepatotoxicity.
    Dodson WE; Tasch V
    Neurology; 1981 Aug; 31(8):1047-50. PubMed ID: 6791048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of valproic acid on hepatic function.
    Willmore LJ; Wilder BJ; Bruni J; Villarreal HJ
    Neurology; 1978 Sep; 28(9 Pt 1):961-4. PubMed ID: 358014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate metabolites in high-dose valproate plus phenytoin therapy.
    Sugimoto T; Muro H; Woo M; Nishida N; Murakami K
    Epilepsia; 1996 Dec; 37(12):1200-3. PubMed ID: 8956852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ketogenic diet and other dietary therapies on anti-epileptic drug concentrations in patients with epilepsy.
    Heo G; Kim SH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):758-764. PubMed ID: 28626875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute hepatic failure associated with valproic acid in children. Report of 3 cases].
    Antoniuk SA; Bruck I; Hönnicke LR; Martins LT; Carreiro JE; Cat R
    Arq Neuropsiquiatr; 1996 Dec; 54(4):652-4. PubMed ID: 9201347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Carbamazepine and Valproate on Serum Aspartate Aminotransferase, Alanine Aminotransferase and Gamma - Glutamyltransferase in Children.
    Hadzagic-Catibusic F; Hasanbegovic E; Melunovic M; Zubcevic S; Uzicanin S
    Med Arch; 2017 Aug; 71(4):239-242. PubMed ID: 28974841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictability of unbound antiepileptic drug concentrations in children treated with valproic acid and phenytoin.
    Miles MV; Snead OC; Thorn MD
    Clin Pharm; 1988 Sep; 7(9):688-93. PubMed ID: 3149223
    [No Abstract]   [Full Text] [Related]  

  • 8. Inverse correlation of valproic acid serum concentrations and quality of life in adolescents with epilepsy.
    Jakovljevic MB; Jankovic SM; Jankovic SV; Todorovic N
    Epilepsy Res; 2008 Aug; 80(2-3):180-3. PubMed ID: 18495431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The platelet aggregation in children with epilepsy receiving valproic acid.
    Tanindi S; Akin R; Koseoglu V; Kurekci AE; Gokcay E; Ozcan O
    Thromb Res; 1996 Feb; 81(4):471-6. PubMed ID: 8907296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein binding of valproic acid in Japanese pediatric and adult patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yamaguchi T; Fujimura A
    Am J Health Syst Pharm; 2002 May; 59(9):835-40. PubMed ID: 12004461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperaminoacidemia in epileptic children treated with valproic acid.
    Castro-Gago M; Rodrigo-Saez E; Novo-Rodriguez I; Camiña MF; Rodriguez-Segade S
    Childs Nerv Syst; 1990 Dec; 6(8):434-6. PubMed ID: 2095300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
    Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of N-Dipropylacetamide serum concentration and its clinical significance in epileptic children].
    Shi FL
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Aug; 19(4):217-20. PubMed ID: 3095059
    [No Abstract]   [Full Text] [Related]  

  • 14. Duration of valproic acid monotherapy correlates with subclinical thyroid dysfunction in children with epilepsy.
    Ilić V; Bogićević D; Miljković B; Ješić M; Kovačević M; Prostran M; Kovačević SV
    Epileptic Disord; 2016 Jun; 18(2):181-6. PubMed ID: 27099936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of valproate monotherapy on the activities of liver enzymes in epileptic children and adolescents].
    Fichsel H
    Nervenarzt; 1982 Dec; 53(12):691-2. PubMed ID: 6130485
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adverse effects of valproic acid in epileptic infants and adolescents].
    Devilat M; Blumel JE
    Rev Chil Pediatr; 1991; 62(6):362-6. PubMed ID: 1845642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of CYP2C9-status guided valproic acid therapy in children.
    Bűdi T; Tóth K; Nagy A; Szever Z; Kiss Á; Temesvári M; Háfra E; Garami M; Tapodi A; Monostory K
    Epilepsia; 2015 Jun; 56(6):849-55. PubMed ID: 25967074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of sodium valproate in childhood epilepsy.
    McQueen JK; Blackwood DH; Minns RA; Brown JK
    Scott Med J; 1982 Oct; 27(4):312-7. PubMed ID: 6815799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index and serum lipid changes during treatment with valproic acid in children with epilepsy.
    Grosso S; Mostardini R; Piccini B; Balestri P
    Ann Pharmacother; 2009 Jan; 43(1):45-50. PubMed ID: 19066323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood ammonia levels in epileptic children on 2 dose ranges of valproic acid monotherapy: a cross-sectional study.
    Sharma S; Gulati S; Kabra M; Kalra V; Vasisht S; Gupta YK
    J Child Neurol; 2011 Jan; 26(1):109-12. PubMed ID: 20921570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.